226 related articles for article (PubMed ID: 19762191)
21. Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis.
Chapoutot C; Esslimani M; Joomaye Z; Ramos J; Perney P; Laurent C; Fabbro-Peray P; Larrey D; Domergue J; Blanc F
Gut; 2000 May; 46(5):711-4. PubMed ID: 10764717
[TBL] [Abstract][Full Text] [Related]
22. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
[TBL] [Abstract][Full Text] [Related]
23. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
[TBL] [Abstract][Full Text] [Related]
24. [Iron overload disease: recent findings].
Licata A; Brucato V; Di Marco V; Barbaria F; Craxì A
Ann Ital Med Int; 2004; 19(3):145-54. PubMed ID: 15529941
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C, iron status, and disease severity: relationship with HFE mutations.
Tung BY; Emond MJ; Bronner MP; Raaka SD; Cotler SJ; Kowdley KV
Gastroenterology; 2003 Feb; 124(2):318-26. PubMed ID: 12557137
[TBL] [Abstract][Full Text] [Related]
26. Iron genes, dysmetabolism and fibrosis in chronic hepatitis C.
Valenti L; Dongiovanni P; Fargion S; Fracanzani AL
J Hepatol; 2008 Mar; 48(3):513-4; author reply 514-5. PubMed ID: 18194822
[No Abstract] [Full Text] [Related]
27. [A study on hepatic iron overload in chronic hepatitis C patients].
Bomfim EA; Pereirade de Oliveira AC; Paraná R; Schinoni MI
Acta Gastroenterol Latinoam; 2013 Sep; 43(3):212-7. PubMed ID: 24303687
[TBL] [Abstract][Full Text] [Related]
28. Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study.
Ganne-Carrié N; Christidis C; Chastang C; Ziol M; Chapel F; Imbert-Bismut F; Trinchet JC; Guettier C; Beaugrand M
Gut; 2000 Feb; 46(2):277-82. PubMed ID: 10644325
[TBL] [Abstract][Full Text] [Related]
29. Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis.
Sorrentino P; D'Angelo S; Ferbo U; Micheli P; Bracigliano A; Vecchione R
J Hepatol; 2009 Feb; 50(2):351-7. PubMed ID: 19070395
[TBL] [Abstract][Full Text] [Related]
30. Hepatic iron overload and hepatocellular carcinoma.
Kew MC
Cancer Lett; 2009 Dec; 286(1):38-43. PubMed ID: 19081672
[TBL] [Abstract][Full Text] [Related]
31. Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
Bonkovsky HL; Naishadham D; Lambrecht RW; Chung RT; Hoefs JC; Nash SR; Rogers TE; Banner BF; Sterling RK; Donovan JA; Fontana RJ; Di Bisceglie AM; Ghany MG; Morishima C;
Gastroenterology; 2006 Nov; 131(5):1440-51. PubMed ID: 17101320
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular carcinoma in a patient with hereditary hemochromatosis and noncirrhotic liver. A case report.
Köhler HH; Höhler T; Küsel U; Kirkpatrick CJ; Schirmacher P
Pathol Res Pract; 1999; 195(7):509-13. PubMed ID: 10448668
[TBL] [Abstract][Full Text] [Related]
33. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
Bugianesi E; Manzini P; D'Antico S; Vanni E; Longo F; Leone N; Massarenti P; Piga A; Marchesini G; Rizzetto M
Hepatology; 2004 Jan; 39(1):179-87. PubMed ID: 14752836
[TBL] [Abstract][Full Text] [Related]
34. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
[TBL] [Abstract][Full Text] [Related]
35. Iron and liver diseases.
Fargion S; Mattioli M; Fracanzani AL; Fiorelli G
Can J Gastroenterol; 2000 Nov; 14 Suppl D():89D-92D. PubMed ID: 11110619
[TBL] [Abstract][Full Text] [Related]
36. Role of liver biopsy in the diagnosis of hepatic iron overload in the era of genetic testing.
Nash S; Marconi S; Sikorska K; Naeem R; Nash G
Am J Clin Pathol; 2002 Jul; 118(1):73-81. PubMed ID: 12109859
[TBL] [Abstract][Full Text] [Related]
37. [HFE gene mutations and risk of hepatocellular carcinoma].
Solís Herruzo JA; Solís Muñoz P
Rev Esp Enferm Dig; 2007 Jul; 99(7):369-75. PubMed ID: 17973579
[No Abstract] [Full Text] [Related]
38. Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients.
Phatak PD; Barton JC
Hematology; 2003 Dec; 8(6):429-32. PubMed ID: 14668040
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of iron status in patients with chronic hepatitis C.
Sartori M; Andorno S; La Terra G; Boldorini R; Leone F; Pittau S; Zecchina G; Aglietta M; Saglio G
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):396-401. PubMed ID: 9789136
[TBL] [Abstract][Full Text] [Related]
40. Iron-overload-related disease in HFE hereditary hemochromatosis.
Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
